Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath

NACompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

October 15, 2022

Conditions
DyspneaUnexplained Chronic Dyspnea
Interventions
OTHER

Education Materials and Janssen Test

"Intervention-1- and Intervention-2-arm participants will receive educational materials duplicating what physicians would receive in the real-world market as they adopt the Janssen technology. These materials are comprised of a slide deck, a sample test report, and a frequently asked questions (FAQ) sheet.~Intervention 1 participants only will receive the Janssen test results whether they select it or not, and Intervention 2 participants will receive the Janssen test results only if they select it during the second round of case simulations."

Trial Locations (1)

94109

QURE Healthcare, San Francisco

All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Qure Healthcare, LLC

INDUSTRY

NCT04693793 - Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath | Biotech Hunter | Biotech Hunter